Friedman; Michael M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Friedman; Michael M..The latest application filed is for "primary carboxamides as btk inhibitors".
- Friedman; Michael M. - Fort Collins CO
- Friedman; Michael M. - Brookline MA
- FRIEDMAN; Michael M. - Kennebunkport ME
- Friedman; Michael M. - Newton MA
- Friedman; Michael M. - Jerusalem IL
| Patent | Date |
|---|---|
| Modulation of rice MPG1 activity to increase biomass accumulation, grain yield, and stress tolerance in plants Grant 11,299,523 - Bush , et al. April 12, 2 | 2022-04-12 |
| Primary Carboxamides As Btk Inhibitors App 20210179556 - Bonafoux; Dominique ; et al. | 2021-06-17 |
| Novel Tricyclic Compounds App 20210061813 - WISHART; Neil ; et al. | 2021-03-04 |
| Inhibitors Of Tyrosine Kinase 2 Mediated Signaling App 20200255423 - Kind Code | 2020-08-13 |
| Inhibitors of tyrosine kinase 2 mediated signaling Grant 10,508,113 - Argiriadi , et al. Dec | 2019-12-17 |
| Primary Carboxamides As Btk Inhibitors App 20190284135 - Bonafoux; Dominique ; et al. | 2019-09-19 |
| Inhibitors Of Tyrosine Kinase 2 Mediated Signaling App 20190276450 - Argiriadi; Maria A. ; et al. | 2019-09-12 |
| Modulation Of Rice Mpg1 Activity To Increase Biomass Accumulation, Grain Yield, And Stress Tolerance In Plants App 20190233480 - Bush; Daniel R. ; et al. | 2019-08-01 |
| Heterocyclic kinase inhibitors Grant 10,280,184 - Friedman , et al. | 2019-05-07 |
| Tricyclic modulators of TNF signaling Grant 10,266,532 - Breinlinger , et al. | 2019-04-23 |
| Substituted cyanoguanidines as oral anti-virals Grant 10,112,911 - Gomtsian , et al. October 30, 2 | 2018-10-30 |
| Novel Tricyclic Compounds App 20180291029 - WISHART; Neil ; et al. | 2018-10-11 |
| Tricyclic Modulators Of Tnf Signaling App 20180179198 - Breinlinger; Eric C. ; et al. | 2018-06-28 |
| Tricyclic modulators of TNF signaling Grant 9,856,253 - Breinlinger , et al. January 2, 2 | 2018-01-02 |
| Primary Carboxamides As Btk Inhibitors App 20170174624 - Bonafoux; Dominique ; et al. | 2017-06-22 |
| Primary carboxamides as BTK inhibitors Grant 9,567,339 - Bonafoux , et al. February 14, 2 | 2017-02-14 |
| Novel Tricyclic Compounds App 20160326181 - Wishart; Neil ; et al. | 2016-11-10 |
| Tricyclic Modulators Of Tnf Signaling App 20160304517 - Breinlinger; Eric C. ; et al. | 2016-10-20 |
| Novel Tricyclic Compounds App 20160222020 - Wishart; Neil ; et al. | 2016-08-04 |
| Tricyclic compounds Grant 9,365,579 - Wishart , et al. June 14, 2 | 2016-06-14 |
| Cyanoguanidines And Uses Thereof App 20150322045 - Gomtsian; Artour ; et al. | 2015-11-12 |
| Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof Grant 9,115,151 - George , et al. August 25, 2 | 2015-08-25 |
| Novel Tricyclic Compounds App 20150210708 - Wishart; Neil ; et al. | 2015-07-30 |
| Tricyclic compounds Grant 8,962,629 - Wishart , et al. February 24, 2 | 2015-02-24 |
| Primary Carboxamides As Btk Inhibitors App 20150005279 - Bonafoux; Dominique ; et al. | 2015-01-01 |
| Triazinone Compounds App 20140206663 - Wang; Jianfei ; et al. | 2014-07-24 |
| Pyrazolopyrimidines as therapeutic agents Grant 7,332,497 - Hirst , et al. February 19, 2 | 2008-02-19 |
| Pyrazolopyrimidines as therapeutic agents Grant 6,921,763 - Hirst , et al. July 26, 2 | 2005-07-26 |
| Pyrazolopyrimidines as therapeutic agents App 20040006083 - Hirst, Gavin C. ; et al. | 2004-01-08 |
| Pyrazolopyrimidines as therapeutic agents Grant 6,660,744 - Hirst , et al. December 9, 2 | 2003-12-09 |
| Pyrazolopyrimidines as therapeutic agents App 20020156081 - Hirst, Gavin C. ; et al. | 2002-10-24 |
| Dental varnish composition, and method of use Grant 5,330,746 - Friedman , et al. July 19, 1 | 1994-07-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 